Antifungal and antidepressant drugs can effectively inhibit COVID-19 virus

New research published in the British Journal of Pharmacology indicates that two currently available medications–an antifungal drug and an antidepressant–can effectively inhibit the virus that causes COVID-19 in laboratory cells.

Investigators found that the antifungal itraconazole and the antidepressant fluoxetine each blocked the production of infectious SARS-CoV-2 virus in cell culture lab tests. When either drug was used in combination with the antiviral drug remdesiver, the combination showed synergistic effects and inhibited the production of SARS-CoV-2 by more than 90%.

Preventive vaccination and therapeutic medicines against COVID-19 are both required to effectively combat pandemics caused by emerging zoonotic viruses such as SARS-CoV-2."

Ursula Rescher, PhD, Study Senior Author, University of Muenster, Germany



Journal reference:

Schloer, S., et al. (2021) Drug synergy of combinatory treatment with remdesivir and the repurposed drugs fluoxetine and itraconazole effectively impairs SARS‐CoV‐2 infection in vitro. British Journal of Pharmacology.

Posted in: Medical Research News | Disease/Infection News | Pharmaceutical News

Tags: Antidepressant, Antifungal, Antiviral Drug, Cell, Cell Culture, Laboratory, Pharmacology, Research, SARS, SARS-CoV-2, Virus

Comments (0)

Source: Read Full Article